Sarcoidosis vasculitis and diffuse lung diseases
Published: 01-06-2010
Editorial
Sarcoidosis requiring systemic treatment: why not a steroid-sparing regimen up-front?
Abstract 166 | PDF (Italian) Downloads 36Page 3-4
Ultrasound endoscopy (EBUS, EUS) as a sophisticated tool for morphological confirmation of Sarcoidosis: do we need to find new answers for an old quest?
Abstract 56 | PDF (Italian) Downloads 30Page 5-6
Review
Epithelial stem cell exhaustion in the pathogenesis of idiopathic pulmonary fibrosis
Abstract 82 | PDF (Italian) Downloads 91Page 7-18
Original Articles: Clinical Research
Is tobacco smoking protective for sarcoidosis? A case-control study from North India
Abstract 41 | PDF (Italian) Downloads 35Page 19-26
Significance of plasma NT-proBNP levels as a biomarker in the assessment of cardiac involvement and pulmonary hypertension in patients with sarcoidosis
Abstract 60 | PDF (Italian) Downloads 64Page 27-35
Perceptions and beliefs in sarcoidosis
Abstract 59 | PDF (Italian) Downloads 47Page 36-42
Minimally invasive diagnosis of sarcoidosis by EBUS when conventional diagnosis fail
Abstract 39 | PDF (Italian) Downloads 59Page 43-48
C-reactive protein predicts response to infliximab in patients with chronic sarcoidosis
Abstract 60 | PDF (Italian) Downloads 61Page 49-56
Original Articles: Laboratory Research
Cathepsin-K is a sensitive immunohistochemical marker for detection of micro-granulomas in hypersensitivity pneumonitis
Abstract 70 | PDF (Italian) Downloads 34Page 57-63
CD24 gene exon 2 dimorphism does not affect disease susceptibility in Japanese sarcoidosis patients
Abstract 43 | PDF (Italian) Downloads 41Page 64-69
Cytokine gene polymorphisms in sarcoidosis
Abstract 136 | PDF (Italian) Downloads 39Page 70-75
Case Reports
Massive pleural effusion and bronchopleural fistula in Wegener’s granulomatosis
Abstract 73 |Page 76-79